Hoping this adds another line for us soon
outsourcing-pharma.com/Arti...
Been researching this for awhile. I believe Veyonda is only in trials in Australia. Hopefully it will be in the states soon.
Maybe. Adding a systemic radiosensitizer: Veyonda (idronoxil) suppository. A phase I/II trial found it was safe, with only anal inflammation attributable to the suppository. Results were no better than trials without the radiosensitizer; however, unlike those other trials, almost all (91%) patients had already received Jevtana.
"Prostate cancer drug demonstrates major survival benefit
02-Mar-2021 By Jenni Spinner
According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer.
HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2021/03/02/PROSTATE-CANCER-TREATMENT-SHOWS-MAJOR-SURVIVAL-BENEFIT
"